Premature Rupture of Membranes UNC School of Medicine Obstetrics and Gynecology Clerkship

Download Report

Transcript Premature Rupture of Membranes UNC School of Medicine Obstetrics and Gynecology Clerkship

Premature Rupture of Membranes

UNC School of Medicine Obstetrics and Gynecology Clerkship Case Based Seminar Series

Objectives for PROM

 List the history, physical findings, and diagnostic methods to confirm the rupture of the membranes  Identify the risk factors for premature rupture of membranes  Describe the risks and benefits of expectant management versus immediate delivery, based on gestational age  Describe the methods to monitor maternal and fetal status during expectant management

Definition

 Premature rupture of membranes (PROM)  Rupture of the chorioamnionic membrane (amniorrhexis) prior to the onset of labor at any stage of gestation  Preterm premature rupture of membranes (PPROM)  PROM prior to 37-wk. gestation

Incidence

   PROM – 12% of all pregnancies PROM – 8% term pregnancies PPROM – 30% of preterm deliveries

PROM/PPROM: History & Physical Exam

 History  “Gush” of fluid  Steady leakage of small amounts of fluid  Physical  Sterile vaginal speculum exam  Minimize digital examination of cervix, regardless of gestational age, to avoid risk of ascending infection/amnionitis  Assess cervical dilation and length  Obtain cervical cultures (Gonorrhea, Chlamydia)  Obtain amniotic fluid samples  Findings   Pooling of amniotic fluid in posterior vaginal fornix Fluid per cervical os

PROM/PPROM: Diagnosis

 Test  Nitrazine test  Fluid from vaginal exam placed on strip of nitrazine paper  Paper turns blue in presence of alkaline (pH > 7.1) amniotic fluid  Fern test  Fluid from vaginal exam placed on slide and allowed to dry  Amniotic fluid narrow fern vs. cervical mucus broad fern

PROM/PPROM: Diagnosis

 False positive Nitrazine test  Alkaline urine  Semen (recent coitus)  Cervical mucus  Blood contamination  Vaginitis (e.g. Trichomonas)  False-Negative Nitrazine test  Remote PROM with no residual fluid  Minimal amniotic leakage

PROM/PPROM: Diagnosis

 Test  Ultrasound  Assess amniotic fluid level and compatibility with PROM  Indigo-carmine Amnioinfusion   Ultrasound guided indigo carmine dye amnioinfusion (“Blue tap”) Observe for passage of blue fluid from vagina

PROM/PPROM: Risk Factors

 Risk Factors:   Prior PROM or PPROM Prior preterm delivery  Multiple gestation   Polyhydramnios Incompetent cervix  Vaginal/Cervical Infection  Gonorrhea, Chlamydia, GBS, S. Aureus  Antepartum bleeding (threatened abortion)   Smoking Poor nutrition

Management: PPROM

(< 24 wk gestation – “previable”)      Patient counseling Expectant management vs. induction of labor GBS prophylaxis NOT recommended Antibiotics  Incomplete data Corticosteriods NOT recommended

Management: PPROM

(< 24 wk gestation – “previable”)  Patient counseling

Gestational Age (In Completed Weeks) Death Before NICU Discharge

Death

Outcomes at 18 to 22 Months Corrected Age*

Death/ Profound Neurodevelopmental Impairment Death/Moderate to Severe Neuro developmental Impairment

22 Weeks 23 Weeks 24 Weeks 25 Weeks

  95% 74% 44% 24% 95% 74% 44% 25% 98% 84% 57% 38% 99% 91% 72% 54% Fetal complications of prolonged PPROM  Pulmonary hypoplasia  Skeletal malformations  Fetal growth restriction  IUFD Maternal complications of prolonged PPROM  Chorioamnionitis http://www.nichd.nih.gov/about/org/cdbpm/pp/prog_epbo/dataShow.cfm

Management: PPROM

(24 – 31 wk gestation)      Expectant management  Deliver at 34 wks  Unless documented fetal lung maturity GBS prophylaxis Antibiotics Single course corticosteroids Tocolytics  No consensus

Management: PPROM

(32 – 33 wk gestation)     Expectant management  Deliver at 34 wks  Unless documented fetal lung maturity GBS prophylaxis Antibiotics Corticosteroids  No consensus, some experts recommend

Management: PROM

(> 34 wk gestation)   Proceed to delivery  Induction of labor GBS prophylaxis

Management: Rationale

  Corticosteroids  Enhance fetal lung maturity  Decrease risk of RDS, IVH, and necrotizing enterocolitis  Antibiotics  Prolong latency period  Prophylaxis of GBS in neonate  Prevention of maternal chorioamnionitis and neonatal sepsis Tocolytics   Delay delivery to allow administration of corticosteroids Controversial, randomized trials have shown no pregnancy prolongation

Management: Drug Regimen

 Antibiotics  Ampicillin 2 g IV Q6 x 48 hrs  Amoxicillin 500 mg po TID x 5 days  Azithromycin 1 g po x 1  Corticosteroids  Betamethasone 12 mg IM q24 x 2  Dexamethasone 6 mg IM q12 x 4  Tocolytics  Nifedipine 10 mg po q20min x 3, then q6 x 48 hrs

Management: Amniocentesis

  Typically performed after 32 wks Tests for fetal lung maturity (FLM)  Lecethin/Sphingomyelin ratio (not commonly used, more for historic interest)  L/S ratio > 2 indicates pulmonary maturity  Phosphatidylglycerol  > 0.5 associated with minimal respiratory distress  Flouresecence polarization (FLM-TDx II)  > 55 mg/g of albumin  Lamellar body count  30,000-40,000  If negative, proceed with expectant management until 34 wks Courtesy of Thomas Shipp, MD.

Management: Surveillance

 Maternal: Monitor for signs of infection  Temperature  Maternal heart rate  Fetal heart rate  Uterine tenderness  Contractions  Fetal: Monitor for fetal well-being  Kick counts  Nonstress tests (NST’s)  Biophysical profile (BPP)

Management: Surveillance

 Immediate Delivery  Intrauterine infection  Abruptio placenta  Repetitive fetal heart rate decelerations  Cord prolapse

Expectant Management vs. Preterm Delivery

 Expectant Management Risks:  Maternal   Increase in chorioamnionitis Increase in Cesarean delivery   Spontaneous labor in ~ 90% within 48 hr ROM Increased risk of placental abruption  Fetal  Increase in RDS  Increase in intraventricular hemorrhage  Increase in neonatal sepsis and subsequent cerebral palsy  Increase in perinatal mortality  Increase in cord prolapse

Expectant Management vs. Preterm Delivery

  Preterm Delivery Risks: use NICHD calculator http://www.nichd.nih.gov/about/org/cdbpm/pp/prog_ep bo/epbo_case.cfm

Gestation (w)

25 24 23 22

Weight

550 500 450 401g

Sex

Female Male Male Female

Steroids Survival

Yes Yes Yes No 64% 35% 16% 2%

Survival w/o profound ND impairment

50% 22% 9% 1%

Bottom Line Concepts

 Preterm premature rupture of membranes refers to rupture of fetal membranes prior to labor in pregnancies < 37 weeks.

 A history of PPROM or PROM, genital tract infection, antepartum bleeding, and smoking are risk factors for PPROM and PROM.

 A clinical history suggestive of PPROM or PROM should be confirmed with visual inspection and laboratory tests including ferning and nitrazine paper.

 Management of PPROM at < 24 wks includes a discussion with the family reviewing the maternal risks against the fetal risks of significant morbidity and mortality during expectant management.

 For women with PPROM or PROM in whom intrauterine infection, abruptio placenta, repetitive fetal heart rate decelerations, or a high risk of cord prolapse is present, immediate delivery is recommended.

 Counseling after the delivery for the recurrence risk of PROM should occur, and modifiable risk factors addressed

References and Resources

 APGO Medical Student Educational Objectives, 9 th edition, (2009), Educational Topic 25 (p52-53).

 Beckman & Ling: Obstetrics and Gynecology, 6th edition, (2010),

Charles RB Beckmann, Frank W Ling, Barabara M Barzansky, William

NP Herbert, Douglas W Laube, Roger P Smith. Chapter 22 (p213-217).

 Hacker & Moore: Hacker and Moore's Essentials of Obstetrics and Gynecology, 5th edition (2009), Neville F Hacker, Joseph C Gambone, Calvin J Hobel. Chapter 12 (p150-153).